BUSCOLYSIN COMPOSITUM
-
| StockNo |
Product description |
| EB0280-444-02 |
BUSCOLYSIN
COMPOSITUM AMPOULE 5 ML |
| EB0280-444-13 |
BUSCOLYSIN
COMPOSITUM FILMTABL X 10 |
| EB0280-444-14 |
BUSCOLYSIN
COMPOSITUM SUPPOSITORIES CHILDREN X 6 |
| EB0280-444-15 |
BUSCOLYSIN
COMPOSITUM SUPPOSITORIES ADULTS X 6 |
-
- COMPOSITION:
Hyoscine-N-butylbromide - 20 mg
Noramidopyrine methansulfonate sodium - 250 mg
in one ampoule
Hyoscine butylbromide - 10 mg
Noramidopyrine methansulfonate sodium - 250 mg
in one filmtablet
Hyoscine butylbromide - 7.5 mg
Noramidopyrine methansulfonate sodium - 250 mg
in one suppository for children
Hyoscine-N-butylbromide - 5 mg
Noramidopyrine methansulfonate sodium - 500 mg
in one suppository for adults
ACTION:
A combined drug with potent spasmolytic and analgesic action.
Buscolysin, included in the drug, blockd the peripheral
M-cholinergic receptors and has a certain N-cholinolytic activity as
regards the sympathetic and parasympathetic autonomic ganglia. It
has a strong spasmoltic effect, lasting for about 6 hours, but with
a relatively lighter effect on the secretion of the gastric,
bronchial and salivary glands. Analgin has an analgesic, antipyretic
and antiphlogistic action, and it potentiates the spasmolytic effect
of buscolysin.
INDIATIONS:
Spasticity of the stomach and duodenum, biliary ducts and urogenital
system. For facilitation of endoscopic examinations and functional
diagnostics during examination of the gastrointestinal tract.
Dysmenorrhea, incipient abortion and spasms of the birth canal.
CONTRAINDICATIONS:
Mechanical stenosis of the gastrointestinal tract. Urine retention
as a result of prostate adenoma, glaucoma, tachycardia and
myasthenia gravis. Allergy to pyrazolone derivatives,
agranulocytosis, thrombocytopenia, hepatic porphyria and congenital
deficit of glucose-6-phosphate dehydrogenase. |
SIDE EFFECTS:
Anticholinergic effects are likely to be observed with higher doses:
inhibition of saliva and sudor secretion, miction disturbances and
acceleration of the cardiac rhythm. Hypersensitivity reactions in
isolated cases: urticarial rash and itching of the skin and muscous
membranes, shock, agranulocytosis and disorders in the renal
function in susceptible patients.
PRECAUTIONS:
The drug is not recommended to be prescribed during pregnancy, with
the exception of the vital indications. It should be administered
cautiously to patients with bronchial asthma because of the risk of
provoking an asthmatic attack.
DOSAGE AND ADMINISTRATION:
Adults - 1-2 tablets orally or 1 suppository for adults rectally,
3-4 times daily. Parenterally in severe spastic states - 1 ampoule
intramuscularly or intravenously, slowly, 2-3 times daily.
Children over 1 year - 1 suppository for children, 1-3 times daily.
MEDICINAL FORM AND PACKAGE:
Packages with 10 and 50 ampoules of 5 ml.
Packages with 10 filmtablets.
Packages of 6 suppositories for adults.
Packages of 6 suppositories for children.
STORAGE:
At moderate temperature (15-30° C).
EXPIRY:
Ampoules 5 (five) years.
Filmtablets 2 (two) years.
Suppositories for children and adults 3 (three) years.
|
